Stoke Therapeutics Executives Sell Shares Amid Market Volatility

Stoke Therapeutics, Inc. has disclosed that its General Counsel and Corporate Secretary, Allan Jonathan, has sold 1,416 shares at $29.56 per share on December 2, 2025, and 868 shares at $30.14 per share on the same day. Additionally, Jonathan has sold 898 shares at $30.34 per share on December 3, 2025, and 1,394 shares at $30.85 per share on that day. The company's Chief Medical Officer, Ticho Barry, has also sold 1,225 shares at $30.85 per share on December 3, 2025, as well as 762 shares at $30.14 per share on December 2, 2025, and 789 shares at $30.34 per share on December 3, 2025. Furthermore, Barry has sold 1,244 shares at $29.56 per share on December 2, 2025.